CEO Q&A with Henry Lees-Buckley at Sativa Group (NEX:SATI)

Sativa Group (NEX:SATI) Chief Executive Officer Henry Lees-Buckley caught up with DirectorsTalk for an exclusive interview to discuss the new appointments in the Group, the progress of the cannabis cultivation project and the company’s admission to AIM.

Q1: Henry, news out on some recent appointments, the first of which being a Product and Procurement Manager. Could you expand on that for us?

A1: Sativa Group is very excited to announce the appointment of Richard Bunce, this will, with Richard’s skill and experience, really take our product management capabilities to a whole new level.

His responsibilities will be to oversee our entire product range, that includes things like product quality, our product compliance, category management, the packaging of all of our products and, most importantly, the expansion of our product range.

So, our intention is to expand the products we offer to all of our customers through each and every brand we have so this is a Sativa-wide initiative, not related to any specific brand but to make sure the quality and compliance etc. is consistent across all of our brands and we’re able to expand our product range in a constituent manner.

So, very pleased to have him on board and he’s already making a big difference.

Q2: The second was for another significant appoint, Director of Retail Sales for Goodbody Botanicals. What’s the plan there?

A2: Goodbody Botanicals is our retail brand so our goal is simply to be the UK’s leading brand on the high street. So, our ambition is to have the Goodbody Botanicals brand available across a number of high street retailers across the UK as soon as we possibly can.

So, we announced earlier our partnership with SHS Distribution who will do our logistics and provide some sales support for us, top shelf firm, highly recognised and respected by all of the high street retailers. So, that was a huge appointment for us in terms of a partner.

Now, the appointment of Alan Horton as the Director of Retail Sales really helps us take this to the next level so we have somebody inside who is also equally focussed on this. Alan will be managing some of our sales team but will also have direct contact with those high street retailers in conjunction with SHS.

So, it’s really just adding some serious horsepower to our high street efforts, at the end of the day, we believe we have a great brand for the high street and now we’ve got a great team with both Alan and SHS really focussed on that effort.

Q3:  You also talk about the progress with the cannabis cultivation project, what can you tell us about that?

A3: Recently, we announced our Home Office licence, which is something we’re extremely proud of, very few companies in the UK have that Home Office Licence. That licence is to grow THC-rich medicinal cannabis, our cannabis product, for medicinal research so it’s really in conjunction with King’s College in London to help and aid their efforts and research.

We kicked that off, we got the Home Office licence and things are progressing very very well. The grow is going exactly as we expected and we’re very proud of the efforts the team has made there to provide King’s College with the product they need for research.

Q4: Just shifting gears, I see that you also plan to move Sativa Group to the London AIM market. How’s that progressing?

A4: Our aim is to definitely be on AIM and do so in the New Year. We’ve enjoyed a very good relationship with the NEX Exchange and we couldn’t thank them enough and we’ve done extremely well with that it.

We heard loud and clear from a number of institutional or intended institutional shareholders, some have the ability and desire to trade on NEX, others don’t, but the message was loud and clear that they’d like to see us on AIM so we’re certainly listening to that.

Quite frankly, that’s our plan. We’ve appointed Cenkos Securities to explore the admission, it’s never a guarantee but we certainly feel we have a very strong case and we’ll plan to work right now and seek admission to the London AIM market early in the New Year.

So, pretty excited about that focus so lots going on here.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Group

    More articles like this

    Sativa Group

    Goodbody Botanicals stores remain open during COVID-19

    At George Botanicals, Goodbody Botanicals and Goodbody Wellness, our customer wellbeing is always at the forefront of what we do.  We’ve been monitoring the development of the COVID-19 situation and have been closely following the advice of

    Sativa Group

    Using CBD in your every day life

    People often ask us here at Goodbody Botanicals, “How should I take CBD?” and we will just say whatever feels best for you. For some people, they will use the oil drops as a tincture, but others may

    Sativa Group

    The Rise of CBD

    CBD stands for cannabidiol, an ingredient made from hemp plant extract – and public interest is growing fast. It’s estimated that the number of British consumers using CBD products has quadrupled over a two-year period to

    Sativa Group

    Sativa Group How distributor alignments are now paying off

    Sativa Group plc (NEX:SATI) CEO Henry Lees-Buckley chats with DirectorsTalk about GoodBody Botanicals being awarded the WH Smith travel business. Henry explains why this is exciting for the company, how its alignment with distributors is paying off, why

    Sativa Group

    How much CBD should you take?

    It’s hard to tell with CBD just how much will work for you, and we’re going to explore ways you can ease into finding what works best for you, as well as why CBD is so

    Sativa Group

    Sativa Group welcomes Food Standard Authority guidelines

    Sativa Group (NEX:SATI) today noted the recent announcement by the Food Standards Agency (“FSA”) concerning the safe use of CBD products and the timetable for Novel Food authorisation.  It welcomes the clarity of a regulatory framework

    Sativa Group

    A focus on the rise of cannabidiol (CBD)

    George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD) Rewind two or three years and CBD wasn’t even on the radar of the fast-moving consumer

    Sativa Group

    Sativa Group Significant progress in 2019

    Sativa Group (NEX:SATI) has today provided a trading update for the year ended 31 December 2019, along with a general business update.  2019 was a year of significant progress for the Group.  The strategic focus and

    Sativa Group

    The most Googled question in the UK… what is CBD?

    What is CBD? Is the single most asked question on Google UK with 2,900 searches a month, it’s been revealed. The questions show there is still confusion about what CBD actually is, if it works and

    Sativa Group

    ‘CBD oil helps me cope with my anxiety’

    Susannah Bell along with other users of cannabidiol, better known as CBD, say it has medicinal benefits and helps her with anxiety, but those who sell it are not allowed to make any medical claims. CBD